"Breakthrough Study Shows MDMA Therapy's Promise for PTSD Treatment"
TL;DR Summary
A Phase III trial has found that MDMA-assisted therapy is effective in relieving symptoms of post-traumatic stress disorder (PTSD) when compared to standard therapy. The study involved over 100 participants with moderate to severe PTSD and showed that 86% of the MDMA group achieved a "clinically meaningful" improvement in symptoms compared to 69% of the control group. The nonprofit organization funding the research plans to seek formal approval from the FDA for MDMA-assisted therapy before the end of the year. If approved, this treatment could provide a valuable new option for individuals who haven't responded to existing medications or therapy.
Topics:top-news#fda-approval#health#mdma-assisted-therapy#multidisciplinary-association-for-psychedelic-studies-maps#phase-iii-trial#ptsd
- Major Trial Finds MDMA-Assisted Therapy Is Effective for PTSD, Paving Way for FDA Approval Gizmodo
- Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval The Associated Press
- MDMA Therapy for PTSD Inches Closer to U.S. Approval The New York Times
- After Latest Clinical Trial, MDMA Therapy For PTSD Is 'On Track' For FDA Consideration Next Year Marijuana Moment
- MDMA-Assisted Therapy Demonstrates Significant Reductions in Post-Traumatic Stress Disorder Symptoms in Phase 3 Study Pharmacy Times
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
84%
645 → 100 words
Want the full story? Read the original article
Read on Gizmodo